Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration

NCT01157065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Exudative Age-Related Macular Degeneration

Interventions

DRUG: AL-78898A
DRUG: Ranibizumab

Sponsor

Alcon Research